Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02622542 · ClinicalTrials.gov registry record · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
A NA study of Distal Aortic Dissection and Dissection, Aortic Acute, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 436
- Enrollment target
- 2
- Study locations
NCT02622542 is a NA study of Distal Aortic Dissection and Dissection, Aortic Acute that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 436 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT02622542, a NA study of Distal Aortic Dissection and Dissection, Aortic Acute, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 436 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to conduct a randomized controlled trial comparing best medical therapy (BMT) alone to BMT with thoracic endovascular aortic repair (BMT+TEVAR) for uncomplicated acute type B aortic dissection.
Conditions Studied
Interventions
- DEVICE BMT+TEVAR
- OTHER BMT
Study Locations (2)
Texas
- Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center - Houston
- Department of Cardiothoracic and Vascular Surgery; Memorial Hermann Hospital Southeast - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 436 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02622542
The ClinicalTrials.gov registry entry for NCT02622542 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 436 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Distal Aortic Dissection appearing as the primary indexed condition, and to 2 interventions - of which BMT+TEVAR is the first listed.
NCT02622542 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02622542 about?
NCT02622542 is a clinical study titled "ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy". The purpose of the study is to conduct a randomized controlled trial comparing best medical therapy (BMT) alone to BMT with thoracic endovascular aortic repair (BMT+TEVAR) for uncomplicated acute type B aortic dissection.
What is the current status of trial NCT02622542?
This trial is currently recruiting. It is a NA study. The enrollment target is 436 participants. The study started on 2018-10-01. Estimated completion is 2026-06.
What conditions does trial NCT02622542 study?
This clinical trial studies the following conditions: Distal Aortic Dissection, Dissection, Aortic Acute, Acute Type B Aortic Dissection (Uncomplicated).
What interventions are being tested in trial NCT02622542?
The interventions under investigation include: BMT+TEVAR (DEVICE), BMT (OTHER).
Who is sponsoring clinical trial NCT02622542?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02622542 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.